Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 054616/0320 | |
| Pages: | 4 |
| | Recorded: | 12/11/2020 | | |
| Attorney Dkt #: | HBC-030 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16980064
|
Filing Dt:
|
09/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/16/2021
| | | | |
|
Title:
|
BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16980064
|
Filing Dt:
|
09/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/16/2021
| | |
PCT #:
|
US2019022062
|
|
Title:
|
BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY
|
|
|
Assignee
|
|
|
|
|
| 3600 CIVIC CENTER BOULEVARD |
| 9TH FLOOR |
| PHILADELPHIA, PENNSYLVANIA 19104 |
|
|
Correspondence name and address
|
| |
GOODWIN PROCTER LLP
|
| |
100 NORTHERN AVENUE
|
| |
BOSTON, MA 02210
|
Search Results as of:
05/14/2024 04:59 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
